{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05918029",
            "orgStudyIdInfo": {
                "id": "2023-14826"
            },
            "secondaryIdInfos": [
                {
                    "id": "R01DK131811",
                    "type": "NIH",
                    "link": "https://reporter.nih.gov/quickSearch/R01DK131811"
                }
            ],
            "organization": {
                "fullName": "Albert Einstein College of Medicine",
                "class": "OTHER"
            },
            "briefTitle": "Bone in CKD Alkali Response (BICARb Pilot Trial)",
            "officialTitle": "Bone in CKD Alkali Response Pilot Trial (BICARb)",
            "acronym": "BICARb",
            "therapeuticArea": [
                "Nephrology and Renal Diseases",
                "Orthopedics"
            ],
            "study": "bone-in-ckd-alkali-response-bicarb-pilot-trial"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-05",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2024-06",
                "type": "ESTIMATED"
            },
            "primaryCompletionDateStruct": {
                "date": "2026-06",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2026-06",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-06-02",
            "studyFirstSubmitQcDate": "2023-06-15",
            "studyFirstPostDateStruct": {
                "date": "2023-06-26",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-05-07",
            "lastUpdatePostDateStruct": {
                "date": "2024-05-08",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Albert Einstein College of Medicine",
                "class": "OTHER"
            },
            "collaborators": [
                {
                    "name": "Columbia University",
                    "class": "OTHER"
                },
                {
                    "name": "University of Pittsburgh Medical Center",
                    "class": "OTHER"
                },
                {
                    "name": "University of Utah",
                    "class": "OTHER"
                },
                {
                    "name": "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)",
                    "class": "NIH"
                }
            ]
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "The goal of this clinical trial is to test whether potassium citrate improves skeletal health in adults and children with chronic kidney disease. The main questions it aims to answer are:\n\n* To evaluate effects of potassium citrate treatment on bone quality and strength.\n* To evaluate mechanism(s) underlying the effects of potassium citrate on skeletal health.\n\nParticipants will be asked to:\n\n* provide blood, urine and answer questions about health and diet three times during an 8 months period\n* undergo advanced bone imaging with high resolution-peripheral quantitative CT scan twice during 8 months\n* take study pills for 4-6 weeks at the beginning of the study to ensure safety\n* take either potassium citrate or placebo for 6 months during the blinded portion of the study\n\nResearchers will compare the bone imaging between the potassium citrate and the placebo groups at the end of the study.",
            "detailedDescription": "Chronic kidney disease is associated with bone loss and fractures in both children and adults, but bone protective therapies that are both proven and safe to use across the life-course in CKD are lacking. In this study, the investigators will conduct a pilot, double-blinded, randomized, placebo-controlled trial in 15 children and 88 adults evaluating the skeletal effects of potassium alkali therapy. These data will form the basis for a larger U01 proposal to determine the efficacy of potassium citrate on mitigating the effects of CKD on bone."
        },
        "conditionsModule": {
            "conditions": [
                "Chronic Kidney Diseases",
                "Bone Loss"
            ],
            "keywords": [
                "Chronic Kidney Disease",
                "Bone strength",
                "Fractures",
                "Pediatrics",
                "Metabolic acidosis"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE2",
                "PHASE3"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "QUADRUPLE",
                    "whoMasked": [
                        "PARTICIPANT",
                        "CARE_PROVIDER",
                        "INVESTIGATOR",
                        "OUTCOMES_ASSESSOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 103,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Potassium Citrate",
                    "type": "EXPERIMENTAL",
                    "description": "Potassium Citrate extended-release tablets 30 mEq twice daily (1 mEq/kg/day divided into two doses for children to a maximum dose of 30 mEq twice daily).",
                    "interventionNames": [
                        "Drug: Potassium citrate"
                    ]
                },
                {
                    "label": "Placebo",
                    "type": "PLACEBO_COMPARATOR",
                    "description": "Placebo capsules identical to the active capsules.",
                    "interventionNames": [
                        "Drug: Placebo"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Potassium citrate",
                    "description": "Oral potassium citrate",
                    "armGroupLabels": [
                        "Potassium Citrate"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Placebo",
                    "description": "Placebo capsule identical to active ingredient",
                    "armGroupLabels": [
                        "Placebo"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Total volumetric bone mineral density (BMD)",
                    "description": "Change in total volumetric bone mineral density (BMD) by high resolution peripheral quantitative computed tomography (HR-pQCT).",
                    "timeFrame": "6 months"
                },
                {
                    "measure": "24 hour net Urine Acid Excretion (NAE)",
                    "description": "Change of urine acid excretion in 24-hour net Urine Acid Excretion (NAE)",
                    "timeFrame": "6 months"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Changes in parathyroid hormone",
                    "description": "Change from baseline to 6 months in median parathyroid hormone levels",
                    "timeFrame": "6 months"
                }
            ],
            "otherOutcomes": [
                {
                    "measure": "Correlation of serum bicarbonate and urine NAE",
                    "description": "Correlation coefficient will be determined between serum bicarbonate and urine net acid excretion. The correlation coefficient is a number between 0 and 1, with 0 being no correlation and 1 being perfect correlation.",
                    "timeFrame": "6 months"
                },
                {
                    "measure": "Correlation of serum bicarbonate and bone quality",
                    "description": "Correlation coefficient will be determined between serum bicarbonate and bone quality. The correlation coefficient is a number between 0 and 1, with 0 being no correlation and 1 being perfect correlation.",
                    "timeFrame": "6 months"
                },
                {
                    "measure": "Correlation between urine net acid excretion and bone quality",
                    "description": "Correlation coefficient will be determined between urine net acid excretion and bone quality. The correlation coefficient is a number between 0 and 1, with 0 being no correlation and 1 being perfect correlation.",
                    "timeFrame": "6 months"
                },
                {
                    "measure": "Changes in bone alkaline phosphatase",
                    "description": "Changes in bone alkaline phosphatase will be compared between the groups. Bone alkaline phosphatase is measured in IU/L. Higher values are indicative of higher bone turnover.",
                    "timeFrame": "6 months"
                },
                {
                    "measure": "Changes in TRAP5b",
                    "description": "Changes in TRAP5b compared between the groups. TRAP5b are measured in mIU/mL.",
                    "timeFrame": "6 months"
                },
                {
                    "measure": "Changes in bone quality",
                    "description": "Bone quality as measured by high resolution peripheral quantitative CT will be compared between groups",
                    "timeFrame": "6 months"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Age \u2265 5 years old\n* For children: Estimated eGFR \\>30 and \\<90 ml/min/1.73m2 by CKiD U25 (For Pediatric participants) equations\n* For adults (\u226518 years old): Estimated eGFR \\>30 and \\<90 ml/min/1.73m2 by the new CKD-Epi without race (For Adults)\n* Females of child-bearing potential must have had a menstrual period in the last month\n* For participants \\< 18 years, the participant and/or parent/guardian capable of providing informed consent and assent (assessed by the provider)\n* Proficiency in English or Spanish\n* PTH and phosphorus levels within the normal range\n* 25-hydroxyvitamin D \u2265 20 ng/mL\n* Women of childbearing potential must be willing to use one form of effective contraception over the course of the study\n\nExclusion Criteria:\n\n* Baseline potassium \\> or = 5.5 mEq/L or prior history of hyperkalemia in the last 6 months (potassium \\>5.5 mEq/L) or currently taking a potassium lowering agent\n* Alkali therapy within the prior 12 months\n* Baseline ECG with abnormalities associated with increased risk of arrythmia, excluding left ventricular hypertrophy\n* Baseline serum bicarbonate levels \\<17 or \\> or = 30 mEq/L\n* Serum calcium \\<8.6 mg/dL, adjusted for serum albumin\n* Significant comorbidity causing acid-base imbalance (e.g. active cancer requiring chemotherapy, chronic liver failure, moderate or severe chronic obstructive lung disease, New York Heart Association class 2 or greater congestive heart failure, obstructive sleep apnea requiring nightly continuous positive airway pressure, active glomerular disease requiring immunosuppressive therapy, intestinal malabsorption or celiac disease)\n* Plans to relocate out of the area in the next 3 months\n* Urine pH \\> 8 or history of nephrolithiasis\n* Lower extremity amputations or non-ambulatory\n* Metabolic bone disease not related to CKD (e.g., Paget's disease, primary hyperparathyroidism)\n* Endocrinopathy: untreated hyper or hypothyroidism, Cushing's syndrome\n* Medical diseases that can affect therapy (severe myocardial damage, acute dehydration, delayed gastric emptying, esophageal compression, or intestinal obstruction or stricture)\n* Use of bisphosphonates, denosumab, teriparatide, abaloparatide, romosozumab, raloxifene, estrogen or testosterone replacement therapy, glucocorticoids within the 12-months prior to enrollment\n* Previous bilateral wrist and tibia fractures\n* Solid or liquid organ transplant\n* On dialysis or with rapidly deteriorating kidney function or expectation for transplantation or initiation of dialysis in less than 3 months\n* Pregnancy or breastfeeding\n* Prisoners or institutionalized individuals\n* Unwillingness to provide informed consent",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "5 Years",
            "maximumAge": "100 Years",
            "stdAges": [
                "CHILD",
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Kimberly Reidy, MD",
                    "role": "CONTACT",
                    "phone": "718-741-2450",
                    "email": "kreidy@montefiore.org"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Kimberly Reidy, MD",
                    "affiliation": "Albert Einstein College of Medicine",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "Albert Einstein College of Medicine",
                    "status": "RECRUITING",
                    "city": "Bronx",
                    "state": "New York",
                    "zip": "10461",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Lisandra Villalba",
                            "role": "CONTACT",
                            "phone": "718-430-3301",
                            "email": "lisandra.ninonuevo@einsteinmed.edu"
                        },
                        {
                            "name": "Kimberly L Reidy, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.84985,
                        "lon": -73.86641
                    }
                },
                {
                    "facility": "University of Pittsburgh Medical Center",
                    "status": "RECRUITING",
                    "city": "Pittsburgh",
                    "state": "Pennsylvania",
                    "zip": "15213",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Juhi Kumar, MD",
                            "role": "CONTACT"
                        },
                        {
                            "name": "Juhi Kumar, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.44062,
                        "lon": -79.99589
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000007674",
                    "term": "Kidney Diseases"
                },
                {
                    "id": "D000051436",
                    "term": "Renal Insufficiency, Chronic"
                }
            ],
            "ancestors": [
                {
                    "id": "D000014570",
                    "term": "Urologic Diseases"
                },
                {
                    "id": "D000052776",
                    "term": "Female Urogenital Diseases"
                },
                {
                    "id": "D000005261",
                    "term": "Female Urogenital Diseases and Pregnancy Complications"
                },
                {
                    "id": "D000091642",
                    "term": "Urogenital Diseases"
                },
                {
                    "id": "D000052801",
                    "term": "Male Urogenital Diseases"
                },
                {
                    "id": "D000051437",
                    "term": "Renal Insufficiency"
                },
                {
                    "id": "D000002908",
                    "term": "Chronic Disease"
                },
                {
                    "id": "D000020969",
                    "term": "Disease Attributes"
                },
                {
                    "id": "D000010335",
                    "term": "Pathologic Processes"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M10698",
                    "name": "Kidney Diseases",
                    "asFound": "Kidney Disease",
                    "relevance": "HIGH"
                },
                {
                    "id": "M26370",
                    "name": "Fractures, Bone",
                    "relevance": "LOW"
                },
                {
                    "id": "M3499",
                    "name": "Acidosis",
                    "relevance": "LOW"
                },
                {
                    "id": "M26717",
                    "name": "Renal Insufficiency, Chronic",
                    "asFound": "Chronic Kidney Disease",
                    "relevance": "HIGH"
                },
                {
                    "id": "M26718",
                    "name": "Renal Insufficiency",
                    "relevance": "LOW"
                },
                {
                    "id": "M17319",
                    "name": "Urologic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M2875",
                    "name": "Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M27093",
                    "name": "Female Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M14127",
                    "name": "Pregnancy Complications",
                    "relevance": "LOW"
                },
                {
                    "id": "M8399",
                    "name": "Female Urogenital Diseases and Pregnancy Complications",
                    "relevance": "LOW"
                },
                {
                    "id": "M27095",
                    "name": "Male Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M6147",
                    "name": "Chronic Disease",
                    "relevance": "LOW"
                },
                {
                    "id": "M22700",
                    "name": "Disease Attributes",
                    "relevance": "LOW"
                },
                {
                    "id": "T1303",
                    "name": "Chronic Graft Versus Host Disease",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BXS",
                    "name": "Urinary Tract, Sexual Organs, and Pregnancy Conditions"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC26",
                    "name": "Wounds and Injuries"
                },
                {
                    "abbrev": "BC18",
                    "name": "Nutritional and Metabolic Diseases"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000019357",
                    "term": "Potassium Citrate"
                }
            ],
            "ancestors": [
                {
                    "id": "D000004232",
                    "term": "Diuretics"
                },
                {
                    "id": "D000045283",
                    "term": "Natriuretic Agents"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                },
                {
                    "id": "D000005100",
                    "term": "Expectorants"
                },
                {
                    "id": "D000019141",
                    "term": "Respiratory System Agents"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M21334",
                    "name": "Potassium Citrate",
                    "asFound": "Proprietary",
                    "relevance": "HIGH"
                },
                {
                    "id": "M21320",
                    "name": "Citric Acid",
                    "relevance": "LOW"
                },
                {
                    "id": "M1837",
                    "name": "Sodium Citrate",
                    "relevance": "LOW"
                },
                {
                    "id": "M7411",
                    "name": "Diuretics",
                    "relevance": "LOW"
                },
                {
                    "id": "M8243",
                    "name": "Expectorants",
                    "relevance": "LOW"
                },
                {
                    "id": "M21137",
                    "name": "Respiratory System Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "T382",
                    "name": "Citrate",
                    "asFound": "Type 2",
                    "relevance": "HIGH"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "NaAg",
                    "name": "Natriuretic Agents"
                },
                {
                    "abbrev": "Resp",
                    "name": "Respiratory System Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "AnCoag",
                    "name": "Anticoagulants"
                },
                {
                    "abbrev": "Ot",
                    "name": "Other Dietary Supplements"
                }
            ]
        }
    },
    "hasResults": false
}